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Abstract. 
 
E- and N-cadherin are members of the classi-
cal cadherin family of proteins. E-cadherin plays an im-
portant role in maintaining the normal phenotype of ep-
ithelial cells. Previous studies from our laboratory and
other laboratories have shown that inappropriate ex-
pression of N-cadherin by tumor cells derived from epi-
thelial tissue results in conversion of the cell to a more
ﬁbroblast-like cell, with increased motility and invasion.
Our present study was designed to determine which do-
mains of N-cadherin make it different from E-cadherin,
with respect to altering cellular behavior, such as which
domains are responsible for the epithelial to mesenchy-
mal transition and increased cell motility and invasion.
To address this question, we constructed chimeric cad-
herins comprised of selected domains of E- and N-cad-
herin. The chimeras were transfected into epithelial
cells to determine their effect on cell morphology and
cellular behavior. We found that a 69–amino acid portion
of EC-4 of N-cadherin was necessary and sufﬁcient to
promote both an epithelial to mesenchymal transition
in squamous epithelial cells and increased cell motility.
Here, we show that different cadherin family members
promote different cellular behaviors. In addition, we
identify a novel activity that can be ascribed to the ex-
tracellular domain of N-cadherin.
Key words: N-cadherin • E-cadherin • cancer • motil-
ity • invasion
 
Introduction
 
Cadherins comprise a family of calcium-dependent cell–
cell adhesion proteins that play important roles in embry-
onic development and maintenance of normal tissue archi-
tecture. As the transmembrane component of cellular
junctions, the cadherins are composed of three segments:
an extracellular domain comprised of five homologous re-
peats that mediate adhesion, a single pass transmembrane
domain, and a conserved cytoplasmic domain that inter-
acts with catenins to link cadherins to the actin cytoskele-
ton (for review see Wheelock et al., 1996). The catenins
were first identified as proteins that coimmunoprecipi-
tated with cadherins and were termed 
 
a
 
-, 
 
b
 
-, and 
 
g
 
-cate-
nin, according to their mobility on SDS-PAGE. Either 
 
b
 
-
or 
 
g
 
-catenin binds directly to the cadherin and 
 
a
 
-catenin,
whereas 
 
a
 
-catenin associates directly and indirectly with
actin filaments (Stappert and Kemler, 1994; Knudsen et
al., 1995; Rimm et al., 1995; Nieset et al., 1997). The ability
of cadherins to simultaneously self-associate and link to
the actin cytoskeleton mediates both the cell recognition
required for cell sorting and the strong cell–cell adhesion
needed to form tissues.
In addition to their structural role in the adherens junc-
tion, catenins are thought to regulate the adhesive activity
of cadherins. For example, phosphorylation of 
 
b
 
-catenin
in Src-transformed cells may contribute to the nonadhe-
sive phenotype of these cells (Matsuyoshi et al., 1992;
Hamaguchi et al., 1993). As a signaling molecule, 
 
b
 
-cate-
nin plays a critical role in patterning during development
and in maintenance of the normal cellular phenotype dur-
ing tumorigenesis (Cadigan and Nusse, 1997; Miller et al.,
1999; Polakis et al., 1999). The signaling functions of
 
b
 
-catenin are due to its interactions with transcription fac-
tors of the lymphoid enhancer factor/T cell factor (LEF/
TCF) family and with receptor tyrosine kinases. In addi-
tion, p120
 
ctn
 
, originally identified as a Src substrate and
subsequently shown to bind to the cytoplasmic domain of
cadherins, has been suggested to play a role in regulating
the adhesive activity of cadherins (Reynolds et al., 1994;
Daniel and Reynolds, 1995; Shibamoto et al., 1995).
p120
 
ctn
 
 binds to the juxtamembrane domain of cadherins, a
domain that has been implicated in cadherin clustering
and cell motility (Chen et al., 1997; Finnemann et al., 1997;
Navarro et al., 1998; Yap et al., 1998). It is thought that
p120
 
ctn
 
 influences the strength of cadherin-mediated adhe-
sion, perhaps by influencing the organization of the actin
cytoskeleton (Aono et al., 1999; Ohkubo and Ozawa, 1999;
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Thoreson et al., 2000). Thus, various studies have shown
that the cytoplasmic domain of cadherins interacts with
proteins that likely regulate adhesive function.
The extracellular domain of classic cadherins is involved
in interactions that mediate adhesion. The earliest evi-
dence for this came from studies demonstrating that anti-
bodies produced against the extracellular domain of cad-
herins inhibit cell adhesion. The extracellular domain of
cadherins can be divided into “extracellular cadherin
structural domains” (EC)
 
1
 
 each of which consists of 
 
z
 
110
amino acids and contains the conserved motifs LDRE,
DXNDN, and DXD (Oda et al., 1994). EC-1 is the most
NH
 
2
 
-terminal domain and is responsible for adhesive ac-
tivity (for review see Takeichi, 1990). The binding sites for
most mAbs that block the adhesive function of E-,
 
 
 
P-,
 
 
 
and
N-cadherin have been mapped to EC-1 (for review see
Takeichi, 1990), a domain that contains an HAV tripep-
tide that has been implicated in adhesion. Synthetic
peptides containing an HAV sequence inhibit cadherin-
mediated adhesion, mimicking the activity of antibodies
directed against EC-1 (Blaschuk et al., 1990). Structural
studies have shown that the HAV tripeptide and its sur-
rounding residues mediate self-association by interacting
with a separate set of amino acids within EC-1 of the inter-
acting cadherin on the adjacent cell (Shapiro et al., 1995).
In addition, mutations in the NH
 
2
 
 terminus of classical
cadherins or deletion of EC-1 results in molecules that do
not mediate cell adhesion (Nose et al., 1990; Ozawa et al.,
1990; Ozawa and Kemler, 1990; Shan et al., 2000).
It was observed that cells expressing different members
of the classical cadherin family segregate from one an-
other when mixed together in culture (for review see
Takeichi, 1990). It has been suggested that this preferen-
tial binding of cadherins plays an important role in the
sorting activities of embryonic cells. Interestingly, the
binding specificity of cadherin molecules also maps to EC-1.
When the NH
 
2
 
-terminal regions of E-cadherin were re-
placed with those of P- or N-cadherin, the chimeric mole-
cules displayed P- or N-cadherin specificity, respectively
(Nose et al., 1990; Shan et al., 2000). Thus, EC-1 of the
classical cadherins is responsible not only for cadherin
binding activity, but also for cadherin specificity.
Various studies have implicated E-cadherin in mainte-
nance of the normal phenotype of epithelial cells (for re-
views see El-Bahrawy and Pignatelli, 1998; Behrens, 1999).
For example, invasive, fibroblast-like carcinoma cells could
be converted to a noninvasive phenotype by transfection
with a cDNA encoding E-cadherin (Frixen et al., 1991),
and forced expression of E-cadherin in rat astrocytoma
cells suppressed motility (Chen et al., 1997). Likewise,
transfection of invasive E-cadherin–negative cell lines with
E-cadherin resulted in cells that were less invasive in in
vitro assays (Frixen et al., 1991; Luo et al., 1999). It has
been suggested that, unlike E-cadherin, N-cadherin may
promote motility and invasion in carcinoma cells. For ex-
ample, Hazan et al. (1997) reported that expression of
N-cadherin by breast carcinoma cells correlated with inva-
sion and suggested that invasion was potentiated by N-cad-
herin–mediated interactions between the cancer and
stromal cells. Studies from our laboratory suggest that
N-cadherin plays a direct role in invasion. Expression of
N-cadherin by squamous epithelial cells resulted in a scat-
tered phenotype accompanied by an epithelial to mesen-
chyme transition. Here, forced expression of N-cadherin in
cultured cells resulted in downregulation of the expression
of E-cadherin (Islam et al., 1996). Thus, it was difficult to
separate the characteristics due to decreased expression of
E-cadherin from those due to increased expression of
N-cadherin. In a second study, we showed that expression
of N-cadherin by BT-20 human breast epithelial cells con-
verted the cells to a motile and invasive phenotype. In this
case, increased motility was not accompanied by decreased
E-cadherin expression, suggesting that N-cadherin plays a
direct role in epithelial cell motility (Nieman et al., 1999a).
Hazan et al. (2000) confirmed our results using the MCF7
human breast carcinoma cell line. Importantly, these au-
thors extended their studies to show that N-cadherin ex-
pression increased metastasis when the transfected cells
were injected into nude mice. Thus, there is evidence that
expression of an inappropriate cadherin may alter cellular
behavior, suggesting that cadherins function as more than
just cell–cell adhesion molecules.
Our study was designed to determine which domains of
N-cadherin are responsible for both the epithelial to mesen-
chymal transition that we have seen in squamous epithelial
cells and the increased motility seen in breast cancer cells.
To address this question, we made use of chimeric cad-
herins constructed between N-cadherin and E-cadherin.
The chimeras were transfected into the SCC1 oral squa-
mous epithelial cell line, to determine their effect on cell
morphology, and into the BT20 breast cancer cell line, to in-
vestigate influences on cell behavior. We found that a 69–
amino acid portion of EC-4 of N-cadherin was both neces-
sary and sufficient to promote motility. This study makes
two important points: (a) it shows that cadherins promote
differential cellular behavior and (b) it identifies a novel ac-
tivity that maps to the extracellular domain of N-cadherin.
 
Materials and Methods
 
Antibodies and Reagents
 
Mouse mAbs against the cytoplasmic domain of human N-cadherin
(13A9), 
 
a
 
-catenin (1G5), and 
 
b
 
-catenin (6E3) have been described previ-
ously (Johnson et al., 1993; Knudsen et al., 1995). Mouse mAbs against the
extracellular amino acids 92–593 of human N-cadherin (8C11) and the cy-
toplasmic domain of human E-cadherin (4A2) were prepared as described
previously (Johnson et al., 1993). Mouse mAb against the myc-epitope
(9E10.2) was a gift from Dr. K. Green (Northwestern University, Chicago,
IL). All reagents were from Sigma-Aldrich, unless otherwise indicated.
 
Cell Culture
 
The human squamous carcinoma cell line UM-SCC-1 (SCC-1) and the hu-
man breast cancer cell line BT20 were maintained in MEM 10% FBS (Hy-
clone Laboratories). A cadherin-negative derivative of A431 called
A431D, which was described previously (Lewis et al., 1997), was main-
tained in DME 10% FBS.
 
Molecular Constructs
 
Human N-cadherin (sequence data available from GenBank/EMBL/
DDBJ under accession no. S42303) (a gift of Dr. A. Ben Ze’ev, Weizmann
Institute, Rehovot, Israel) and human E-cadherin (sequence data avail-
 
1
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able from GenBank/EMBL/DDBJ under accession no. Z13009) (Lewis et
al., 1997) were used for construction of chimeric cadherins using recombi-
nant PCR (Higuchi et al., 1988). In each case, the recombinant PCR prod-
uct was subcloned and representatives were sequenced until one was iden-
tified that encoded the complete, correct amino acid sequence. Each
full-length construct was assembled by joining restriction fragments from
the correct recombinant PCR product and the cDNA clones. The full-
length construct was moved into pLKneo (Hirt et al., 1992) or a derivative
for transfection into cells. Amino acid sequences across the chimeric junc-
tions are given in Table I. Brief descriptions of the constructions are given
below; complete details are available upon request.
The E/N-chimera has the extracellular and transmembrane domains of
E-cadherin and the cytoplasmic domain of N-cadherin, whereas the N/E-
chimera has the extracellular and transmembrane domains of N-cadherin
and the cytoplasmic domain of E-cadherin. To construct the E/N-chimera,
recombinant PCR was used to generate a chimeric cDNA encoding a por-
tion of E-cadherin’s extracellular domain, including the unique Bsu36I
site, plus its transmembrane domain and N-cadherin’s entire cytoplasmic
domain. To complete the full-length E/N-chimera, a 5
 
9
 
 E-cadherin cDNA
fragment was ligated to the recombinant PCR product at the Bsu36I site.
A similar strategy was employed to form the N/E-chimera, except the
unique BglII site located in the N-cadherin sequence was used to join the
5
 
9
 
 N-cadherin cDNA fragment to the recombinant PCR product. The full-
length chimeras were inserted into pLKneo for transfection.
To make the N/E-myc construct, the cytoplasmic domain of E-cad-
herin, including the unique SmaI site, was amplified such that the stop
codon was replaced with a restriction site. The PCR product was inserted
into a modified pSPUTK (Falcone and Andrews, 1991) to add a COOH-
terminal 2X-myc tag (Nieman et al., 1999a). A 5
 
9
 
 restriction fragment
from the N/E-chimera was ligated to the above construct at the SmaI site
to make the full-length N/E-myc cDNA. To make N/E5a-myc, N/E5-myc,
and N/E4-myc, recombinant PCR fragments were used to replace portions
of the N/E-myc construct by using convenient restriction sites. To make
N/E3-myc, a recombinant PCR fragment was used to replace a portion of
the N/E4-myc construct. In a similar fashion, the N/E2-myc construct was
made by replacing a portion of the N/E3-myc construct with a recombi-
nant PCR fragment. Each of these full-length cadherins was then inserted
into pLKpac (Islam et al., 1996) for transfection.
The E/N/E-myc chimera was generated by substituting nucleotides en-
coding N-cadherin amino acids 535–603 for the corresponding E-cadherin
sequence. Recombinant PCR was performed to create the 5
 
9
 
 junction be-
tween E- and N-cadherin. The product of this reaction was used in a sec-
ond recombinant PCR step to create the 3
 
9
 
 junction between N- and
E-cadherin. The resulting PCR product was used to replace a portion of
E-cadherin–2X-myc (Nieman et al., 1999b). The N/E/N-myc construct was
prepared similarly. In this case, the final PCR product was used to replace
a portion of the N-cadherin sequence in an N-cadherin–2X-myc construct.
The chimeras were inserted into pLKpac for transfection.
 
Transfections
 
SCC1 and A431D cells were transfected, using calcium phosphate and
BT20, by electroporation, as previously described (Nieman et al., 1999a).
Stable clones were selected by growth in puromycin (1 
 
m
 
g/ml) or G418 (1
mg/ml). Clones were screened for transgene expression by immunoblot
analysis. Clones that showed homogenous expression by immunofluores-
cence were selected. For morphological studies, at least three clones from
each transfection were examined.
 
Microscopy
 
Cells were grown on glass coverslips, fixed with Histochoice (Amresco),
blocked using PBS 10% goat serum, and stained with primary antibodies
for 1 h, followed by treatment with a secondary antibody (Jackson Immu-
noResearch Laboratories). Photos were taken with a ZEISS Axiophot mi-
croscope (ZEISS) equipped with a SPOT CCD camera (Spot Diagnostic).
 
Cell Fractionation and Protein Assays
 
Confluent monolayers were washed with PBS and extracted on ice with
TNE buffer (10 mM Tris-acetate, pH 8.0, 0.5% NP-40, 1 mM EDTA, 2
mM PMSF). Extracts were mixed at 4
 
8
 
C for 30 min and centrifuged at
15,000 rpm for 15 min. Protein determinations were done using a Bio-Rad
kit (Bio-Rad Laboratories).
 
Immunoprecipitations, Electrophoresis, and 
Immunoblot Analysis
 
A 300-
 
m
 
l aliquot of cell extract was incubated with 300 
 
m
 
l hybridoma su-
pernatant for 30 min at 4
 
8
 
C. Protein A beads were added, and the incuba-
tion was continued for 30 min. Immune complexes were washed with
TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.5% Tween 20) 5
 
3
 
 at
4
 
8
 
C. Pellets were resolved by SDS-PAGE and immunoblotted as de-
scribed previously (Johnson et al., 1993).
 
Aggregation Assays
 
Aggregation assays were done as described by Redfield et al. (1997), with
minor modifications. In brief, cells were trypsinized and resuspended at
2.5 
 
3
 
 10
 
5
 
 cells/ml in the appropriate medium containing 10% FBS. 20-
 
m
 
l
drops of medium, containing 5,000 cells/drop, were pipetted onto the in-
ner surface of the lid of a petri dish. The lid was then placed on the petri
dish so that the drops were hanging from the lid with the cells suspended
within them. To eliminate evaporation, 10 ml serum-free culture medium
was placed in the bottom of the petri dish. After 24 h at 37
 
8
 
C, the lid of the
petri dish was inverted and photographed using a ZEISS inverted tissue
culture microscope at 100
 
3
 
 magnification.
 
Motility Assays
 
For motility assays, 5
 
 3 
 
10
 
5
 
 cells were plated in the top chamber of non-
coated polyethylene teraphthalate membranes (six-well insert, pore size 8
mm) (Becton Dickinson). 3T3-conditioned medium was used as a
chemoattractant in the lower chamber. The cells were incubated for 24 h,
and the cells that did not migrate through the pores in the membrane were
removed by scraping the membrane with a cotton swab. Cells transversing
the membrane were stained with Diff-Quick (Dade). Cells in 10 random
fields of view at 100
 
3
 
 magnification were counted and expressed as the av-
erage number of cells/field of view. Three independent experiments were
done in each case. The data was represented as the average of the three in-
dependent experiments with the standard deviation of the average indi-
cated. When cells were induced with dexamethasone to express a trans-
gene, the control cells were treated with the same level of dexamethasone.
 
Antibody Blocking Experiments
 
Ascites fluid generated from the 8C11 mAb or control ascites was diluted
in culture medium. Cells were plated on membranes for motility assays, as
described above, except that the cells were plated in medium-containing
ascites fluid. After 24 h, the number of cells traversing the membrane was
determined.
 
Results
 
Previous studies from our laboratory showed that expres-
sion of N-cadherin by squamous epithelial cells or breast
cancer cells altered cellular behavior. In oral squamous ep-
ithelial cells, expression of N-cadherin produced a scat-
tered phenotype with an epithelial to mesenchymal transi-
 
Table I.
 
Chimera Junction Details
 
E/N 
 
LLFL/KRRD
 
Joins E-cad 731 to N-cad 747 
N/E and N/E myc
 
VVWM/RRRA
 
Joins N-cad 746 to E-cad 732 
N/E5a myc
 
AGPF/TAEL
 
Joins N-cad 637 to E-cad 627
N/E5 myc
 
DNAP/IPEP
 
Joins N-cad 603 to E-cad 594
N/E4 myc
 
NIRY/RIWR
 
Joins N-cad 534 to E-cad 524
N/E3 myc
 
NAVY/TILN
 
Joins N-cad 420 to E-cad 414 
N/E2 myc
 
MLRY/TILS
 
Joins N-cad 306 to E-cad 303
E/N/E myc 5
 
9
 
3
 
9
 
KITY/TKLS
DNAP/IPEP
 
Joins E-cad 523 to N-cad 535
Joins N-cad 603 to E-cad 594
N/E/N myc 5
 
9
 
3
 
9
 
NIRY/RIWR
DNAP/QVLP
 
Joins N-cad 534 to E-cad 524
Joins E-cad 593 to N-cad 604
 
In our N-cadherin cDNA, there is an additional leucine (CTG) after amino acid 11.
Thus, the entire open reading frame is 906 codons. The numbers in the table reflect this
change to S42303. The E-cadherin cDNA has an open reading frame of 882 codons. 
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Figure 1. Expression of E/N- and N/E-cadherin in A431D cells. (A) Chimeric cadherins consisting of the extracellular and trans-
membrane domains of E-cadherin (white) and the cytoplasmic domain of N-cadherin (gray) or consisting of the extracellular and
transmembrane domains of N-cadherin and the cytoplasmic domain of E-cadherin were cloned into pLKneo2. (B) A431D cells
were transfected with N-cadherin, E-cadherin, E/N-cadherin, or N/E-cadherin and examined for transgene expression by immu-
noblotting with antibodies against the cytoplasmic domain of N-cadherin (lanes 1, 2, and 4), the extracellular domain of N-cad-
herin (lane 5), or the extracellular domain of E-cadherin (lane 3). Note, in some cases, we observed various processing variants
when transfected cadherins were overexpressed in cells. (C) Extracts were immunoprecipitated, resolved by SDS-PAGE, and im-
munoblotted for b-catenin. (D) Untransfected A431D cells (a–d) or A431D cells expressing N-cadherin (e and f), E-cadherin (g
and h), E/N-cadherin (f and g), or N/E-cadherin (h and i) were processed for immunofluorescence microscopy using the appropri-
ate cadherin antibody. Corresponding phase and fluorescence micrographs are shown. (E) Untransfected A431 D cells (a) or
A431D cells expressing E-cadherin (b), N-cadherin (c), E/N-cadherin (d), or N/E-cadherin (e) were tested for their ability to ag-
gregate in a hanging drop aggregation assay. Bar, 10 mm. 
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tion (Islam et al., 1996). In breast cancer cells, expression
of N-cadherin did not alter the morphology of the cells,
but did induce cell motility and invasion (Nieman et al.,
1999a). Here, we sought to determine how N-cadherin
functioned to alter the phenotype of epithelial cells. We
predicted that the cytoplasmic domain of N-cadherin was
capable of initiating a signal transduction pathway that re-
sulted in increased cellular motility. To determine if this
was the case, we engineered two chimeric cadherins. The
first, called E/N-cadherin, consisted of the extracellular
and transmembrane domains of E-cadherin joined to the
cytoplasmic domain of N-cadherin. The second chimera
consisted of the extracellular and transmembrane domains
of N-cadherin joined to the cytoplasmic domain of E-cad-
herin (N/E-cadherin). A schematic of these two chimeric
cadherins is presented in Fig. 1 A.
 
The Extracellular Domain of N-Cadherin Influences 
Epithelial Cell Behavior
 
Our goal was to test E/N-cadherin and N/E-cadherin for
effects on cellular morphology and behavior using two
model systems we had already established. In the first
model system, the oral squamous epithelial cell line
SCC1 undergoes a significant and readily discernible
morphological change from a typical epithelial cell to a
fibroblastic cell, when transfected with N-cadherin (Islam
et al., 1996). In the second model system, the human
breast cancer cell line BT20 changes from a relatively
nonmotile to a highly motile cell when transfected with
N-cadherin (Nieman et al., 1999a). Interestingly, the
BT20 cells do not undergo a morphological change when
they are transfected with N-cadherin, suggesting that the
effects of N-cadherin differ somewhat between these two
different types of epithelial cells. Before testing the effect
our chimeric cadherins had on the morphology and be-
havior of cells, it was important to show that each chi-
mera was a functional adhesion molecule. To determine
if the chimeras were functional, we transfected them into
the cadherin-negative A431D cell line, which has been
previously described by our laboratory (Lewis et al.,
1997; Thoreson et al., 2000). Fig. 1 shows that the chi-
meric cadherins were expressed by the A431D cells at
the expected size (Fig. 1 B), that they associated with
catenins in an immunoprecipitation assay (Fig. 1 C), that
they were located at the cell surface (Fig. 1 D), and that
they mediated cell aggregation (Fig. 1 E). These data
demonstrate that both E/N-cadherin and N/E-cadherin
function as adhesion molecules in a manner similar to E-cad-
herin or N-cadherin. Surprisingly, the morphology of
A431D cells transfected with E-cadherin did not differ
significantly from that of A431D cells transfected with
N-cadherin. In addition, the morphology of A431D cells
transfected with the chimeras was similar to A431D cells
transfected with either E-cadherin or N-cadherin.
Figure 2. Expression of E/N- and N/E-cadherin in SCC1 cells. (A) SCC1 cells were transfected with E/N- or N/E-cadherin and examined
for transgene expression by immunoblotting with antibodies against the cytoplasmic (lane 1) or extracellular (lane 2) domain of N-cad-
herin. (B) Extracts were immunoprecipitated, resolved by SDS-PAGE, and immunoblotted for b-catenin. (C) Untransfected SCC1 cells (a
and b) or SCC1 cells expressing N-cadherin (c and d), E/N-cadherin (e and f), or N/E-cadherin (g and h) were processed for immunofluo-
rescence microscopy using the appropriate cadherin antibody. Corresponding phase and fluorescence micrographs are shown. Bar, 15 mm. 
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E/N-cadherin and N/E-cadherin were transfected into
SCC1 cells and analyzed for their ability to induce an epi-
thelial to mesenchymal transition. Each chimera was
highly expressed (Fig. 2 A), coimmunoprecipitated with
 
b
 
-catenin (Fig. 2 B), and localized at the cell surface (Fig.
2 C, f and h). To our surprise, the N/E-cadherin (Fig. 2 C, g)
produced a change in morphology similar to that seen with
intact N-cadherin (Fig. 2 C, c), whereas the E/N-cadherin
did not effect the morphology of these cells (Fig. 2 C, e).
To determine if the extracellular domain of N-cadherin
was also responsible for the change in motility of BT20
cells, we transfected N/E-cadherin and E/N-cadherin into
these cells. Fig. 3 A shows that both chimeric cadherins
were expressed at the cell surface and that neither chimera
produced an effect on the morphology of these cells. This
is consistent with our previous studies showing that N-cad-
herin did not effect the morphology of BT20 cells (Nieman
et al., 1999a) (Fig. 3 A, c). Fig. 3 B shows that N/E-cad-
herin was as efficient as intact N-cadherin at inducing mo-
tility in BT20 cells, whereas E/N cadherin did not signifi-
cantly alter the motile characteristics of BT20 cells. Thus,
our hypothesis that the cytoplasmic domain of N-cadherin
initiates a signaling pathway, resulting in increased cell
motility, was not substantiated. Rather, it appeared that
the extracellular domain of N-cadherin was responsible
for the epithelial to mesenchymal transition in squamous
epithelial cells and increased motility in breast cancer
cells. The remainder of this study was aimed at determin-
ing which part of the extracellular domain of N-cadherin
influenced cellular morphology and behavior.
 
Extracellular Domain 4 of N-Cadherin Confers a 
Motile Phenotype on Epithelial Cells
 
To further investigate the extracellular domain of N-cad-
herin, we constructed additional chimeric cadherins. We
started with N/E-cadherin and moved the boundary be-
tween N- and E-cadherin progressively towards the NH
 
2
 
terminus (Fig. 4 A). We added a myc tag to the COOH
terminus of the chimeras so that we could use the identical
antibody to detect each chimera. We also constructed a
chimeric N/E-cadherin with a myc tag (N/E-myc) to
ensure addition of the tag did not alter the ability of
N/E-cadherin to confer a motile phenotype on human epi-
thelial cells. The chimeric cadherin that included approxi-
mately one third of EC5 of E-cadherin was designated
N/E5a-myc; the chimeric cadherin that included EC5 of
E-cadherin was designated N/E5-myc; the chimeric cad-
herin that included EC5 and most of EC4 of E-cadherin
was designated N/E4-myc; the chimeric cadherin that in-
cluded EC5, EC4, and most of EC3 of E-cadherin was des-
ignated N/E3-myc; and the chimeric cadherin that in-
cluded EC5, EC4, EC3, and most of EC2 of E-cadherin
was designated N/E2-myc (Fig. 4 A).
Each chimera was transfected into the cadherin-nega-
tive A431D cells to determine if it functioned properly as
an adhesion molecule. The N/E-cadherin with a 2X-myc
Figure 3. Expression of E/N- and N/E-cadherin in BT20 cells. (A) BT20 cells were
transfected with full-length N-cadherin (BT20N), E/N-cadherin, or N/E-cadherin. Un-
transfected BT20 cells (a and b) or BT20 cells expressing N-cadherin (c and d), E/N-cad-
herin (e and f), or N/E-cadherin (g and h) were processed for immunofluorescence mi-
croscopy using the appropriate cadherin antibody. Corresponding phase and
fluorescence micrographs are shown. Bar, 15 mm. (B) Cells were plated on membranes
for motility assays, incubated for 24 h, and the number traversing the membrane was de-
termined by averaging 10 random fields. Data are expressed as the number of cells/field.
Each experiment was done three times and error bars indicate SD. 
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tag (N/E-myc-cadherin) behaved exactly like N/E-cad-
herin, indicating that the myc tag did not influence the
function of the chimeric cadherin. Chimeras N/E-myc,
N/E5-myc, N/E4-myc, and N/E3-myc were each expressed
at a high level, as indicated by immunoblot analysis using
anti-myc antibodies (Fig. 4 B). The proteins were pro-
cessed to the predicted size, though there was more un-
processed protein than was seen for endogenous cad-
herins, E/N-cadherin, or N/E-cadherin. Each chimera
efficiently associated with 
 
b
 
-catenin, as demonstrated by
coimmunoprecipitation (Fig. 4 C). In addition, each chi-
mera mediated cell aggregation (Fig. 4 D). Chimeras
N/E5a-myc and N/E2-myc were not properly processed or
did not mediate adhesion in A431D cells, so we did not
use them in assays to map the domain of N-cadherin that
functions to induce motility in epithelial cells.
When N/E-myc, N/E5-myc, N/E4-myc, and N/E3-myc
chimeric cadherins were transfected into SCC1 cells, they
were highly expressed (Fig. 5 A) and coimmunoprecipitated
with 
 
b
 
-catenin (Fig. 5 B). The N/E-myc and N/E5-myc chi-
meras produced the same morphological change in SCC1
cells that was seen with N/E-cadherin (Fig. 5 C, a and c). In
contrast, the N/E4-myc and N/E3-myc chimeras had no ef-
fect on the morphology of SCC1 cells (Fig. 5 C, e and g).
We were equally interested in the ability of these addi-
tional chimeric cadherins to influence cellular motility. We
typically use the BT20 cells for this assay, since we have es-
tablished a clear difference between N-cadherin–express-
ing and –nonexpressing BT20 cells. In addition, we wanted
to be sure we were looking at the same phenomenon we
had previously published (Nieman et al., 1999a). However,
the BT20 cells grow slowly in culture and are difficult to
transfect. We have not been successful at establishing
BT20 cell lines expressing the additional chimeras. There-
fore, we established a motility assay that made use of the
already transfected A431D cells. We first showed that
A431D cells transfected with N-cadherin were more mo-
tile than untransfected A431D cells or A431D cells trans-
fected with E-cadherin (Fig. 5 D). In addition, we showed
that A431D cells transfected with E/N-cadherin behave
similarly to A431 cells transfected with intact E-cadherin,
and A431D cells transfected with N/E-cadherin behave
like A431D cells transfected with intact N-cadherin. Thus,
we believe we are testing the same N-cadherin–mediated
effect on motility whether we use the BT20 system or the
A431D system. A431D cells transfected with the N/E5 chi-
mera were as motile as those transfected with full-length
N-cadherin or with the N/E chimera, whereas the motility
rates of cells transfected with the N/E4 and N/E3 chimeras
were similar to the motility rates of cells transfected with
E-cadherin or with the E/N chimera. Thus, we determined
that the domain of N-cadherin, which is responsible for the
epithelial to mesenchymal transition when expressed in
squamous epithelial cells, is most likely the same domain
that increases cell motility when N-cadherin is expressed
in epithelial cells. This domain probably resides in EC4,
most likely the region including amino acids 535–603.
 
Extracellular Domain 4 Is Sufficient to Confer a Motile 
Phenotype on Epithelial Cells
 
To confirm that extracellular domain 4 of N-cadherin
alone was responsible for altering the behavior of epithe-
lial cells, we constructed two additional chimeric cad-
herins. The first was E-cadherin, except that amino acids
535–603 of N-cadherin replaced the corresponding portion
of E-cadherin and was called E/N/E-cadherin (Fig. 6 A).
The second chimera was N-cadherin, except that amino
acids 535–603 of N-cadherin were replaced by the corre-
Figure 4. Generation of additional cadherin chimeras. (A) Chimeric cadherins, with a 2X-myc tag at the COOH terminus, consisting of
E-cadherin (white) and N-cadherin (gray), were cloned into pLKpac. (B) A431D cells were transfected and examined for transgene ex-
pression by immunoblotting with anti-myc. Note, in some cases, we observed various processing variants when transfected cadherins
were overexpressed in cells. (C) Extracts were immunoprecipitated using anti-myc, resolved by SDS-PAGE, and immunoblotted for
b-catenin. (D) A431D cells expressing N/E-myc-cadherin (a), N/E5-myc-cadherin (b), N/E4-myc-cadherin (c), or N/E3-myc-cadherin
(d) were tested for their ability to aggregate in a hanging drop aggregation assay. Bar, 15 mm. 
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sponding amino acids of E-cadherin (N/E/N-cadherin).
Both chimeras included a 2X-myc tag. When transfected
into the cadherin-negative A431D cells, both the E/N/E-
cadherin and the N/E/N-cadherin were highly expressed,
coimmunoprecipitated with 
 
b
 
-catenin (Fig. 6 B), and effi-
ciently mediated cell aggregation (Fig. 6 C). In addition,
each chimera was expressed at cell borders in SCC1 cells
(Fig. 6 D). The E/N/E chimera produced the epithelial to
mesenchymal transition seen with full-length N-cadherin
(Fig. 6 D, a), whereas the N/E/N chimera did not (Fig. 6 D,
c). When A431D cells were transfected with the E/N/E-
cadherin, they showed motility rates similar to that seen
when the cells were transfected with full-length N-cad-
herin. In contrast, the N/E/N transfected cells showed mo-
tility rates similar to E-cadherin–transfected cells (Fig. 6
E). Thus, this short 69–amino acid segment of N-cadherin
was both necessary and sufficient to cause the morpholog-
ical and behavioral changes seen in epithelial cells.
Figure 5. Expression of additional N/E-cadherin chimeras. (A) SCC1 cells were transfected with N/E-myc-cadherin, N/E5-myc-cadherin,
N/E4-myc-cadherin, or N/E3-myc-cadherin and examined for transgene expression by immunoblotting with anti-myc. (B) Extracts were
immunoprecipitated using anti-myc, resolved by SDS-PAGE, and immunoblotted for b-catenin. (C) SCC1 cells transfected with N/E-myc-
cadherin (a and b) N/E5-myc-cadherin (c and d), N/E4-myc-cadherin (e and f), or N/E3-myc-cadherin (g and h) were processed for immu-
nofluorescence microscopy using anti-myc. Corresponding phase and fluorescence micrographs are shown. Bar, 15 mm. (D) A431D cells
either nontransfected or transfected with N-cadherin (A431D-N), E-cadherin (A431D-E), E/N-myc-cadherin (A431D-E/N), N/E-myc-
cadherin (A431D-N/E), N/E5-myc-cadherin (A431D-N/E5), N/E4-myc-cadherin (A431D-N/E4), or N/E3-myc-cadherin (A431D-N/E3)
were plated on membranes for motility assays, incubated for 24 h, and the number traversing the membrane was determined by averaging
10 random fields. Data are expressed as the number of cells/field. Each experiment was done three times and error bars indicate SD. 
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Antibodies Directed against the Extracellular Domain 
of N-Cadherin Inhibit Motility in Epithelial Cells
 
The domain of classical cadherins that is responsible for
cell adhesion resides in EC1. Antibodies directed against
EC1 inhibit cadherin-mediated cell–cell interactions. Thus,
we sought to determine if the ability of N-cadherin to in-
fluence cellular behavior could be inhibited by antibodies
that bind to EC4. We immunized mice with the entire ex-
tracellular domain of human N-cadherin and chose those
antibodies that mapped near EC4 for these studies. Fig. 7
A shows that one antibody, 8C11, bound to chimeric cad-
herins N/E-myc, N/E5a-myc, N/E5-myc, and N/E4-myc,
but not to N/E3-myc or N/E2-myc. The control anti-myc
antibody recognized each chimeric cadherin. When 8C11
was added to BT20N cells in a motility assay, it inhibited
motility in a dose-dependent manner, indicating that this
antibody did bind near the domain of N-cadherin that was
responsible for altering the behavior of these cells (Fig. 7
 
B). We used the antibody at a dilution of 1:10 to repeat the
experiment and to determine if it had any effect on N-cad-
herin–negative cells. For this experiment, we used smaller
filters and counted the number of cells traversing the en-
tire filter. The 8C11 antibody had minimal effect on the
motility of N-cadherin–negative cells (Fig. 7 C). In addi-
tion, an irrelevant ascites (4A2), used at a dilution of 1:10,
had minimal effect on the motility of BT20N or on the mo-
tility of untransfected BT20 cells (Fig. 7 C). However, the
mAb 8C11 significantly decreased cell motility in the
N-cadherin–expressing BT20N cells. Importantly, even at
a 1:10 dilution in the mAb 8C11 did not inhibit cell aggre-
gation in N-cadherin–expressing cells (data not shown). In
an initial experiment, the 8C11 antibody did not produce a
significant change in morphology when applied to N-cad-
herin–expressing SCC1 cells (data not shown). These re-
sults are unexpected and are being further investigated in
our laboratory.
Figure 6. Generation and expression of E/N/E- and N/E/N-cadherins. (A) Chimeric
cadherins consisting of E-cadherin (white) and N-cadherin (gray) were constructed
and cloned into pLKpac with a 2X-myc tag at the COOH terminus. (B) A431D cells
were transfected and examined for transgene expression by immunoblotting with
anti-myc (lanes 1 and 2). Extracts were immunoprecipitated using anti-myc, resolved
by SDS-PAGE, and immunoblotted for b-catenin (lanes 3 and 4). (C) A431D cells
expressing E/N/E-myc-cadherin (a) or N/E/N-myc-cadherin (b) were tested for their
ability to aggregate in a hanging drop aggregation assay. (D) SCC1 cells transfected
with E/N/E-myc-cadherin (a and b) or N/E/N-myc-cadherin (c and d) were processed
for immunofluorescence microscopy using anti-myc. Corresponding phase and fluo-
rescence micrographs are shown. Bar, 15 mm. (E) A431D cells transfected with E-cad-
herin (A431D-E), N-cadherin (A431D-N), E/N/E-myc-cadherin (E/N/E), or N/E/N-myc-cadherin (N/E/N) were plated on mem-
branes for motility assays, incubated for 24 h, and the number traversing the membrane was determined by averaging 10 random
fields. Data are expressed as the number of cells/field. Each experiment was done three times and error bars indicate SD. 
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Discussion
 
We and others have shown that N-cadherin influences the
morphology and behavior of epithelial cells (Islam et al.,
1996; Hazan et al., 1997, 2000; Li et al., 1998). These stud-
ies implicate N-cadherin in an epithelial to mesenchymal
transition in some cells, but not in others. In squamous ep-
ithelial cells, expression of N-cadherin results in downreg-
ulation of E-cadherin, which is most likely responsible for
the change in cellular morphology. In other cells, such as
breast cancer cells, expression of N-cadherin does not alter
cell morphology, but does alter cellular behavior by induc-
ing a motile phenotype. In breast cancer cells, expression
of E-cadherin remains approximately the same when the
cells are forced to express N-cadherin. This suggests that
even in cells that express abundant E-cadherin, N-cad-
 
herin influences cell behavior. N-cadherin is often ex-
pressed by motile cells, such as fibroblasts, and a switch
from E-cadherin expression to N-cadherin expression oc-
curs when some cells become motile and/or invasive dur-
ing normal developmental processes (Edelman et al., 1983;
Hatta and Takeichi, 1986; Zhou et al., 1997; Huttenlocher
et al., 1998). Thus, it is not unexpected that expression of
N-cadherin by tumor cells alters cellular morphology and/
or behavior.
The extracellular domain of a cadherin promotes cell–
cell adhesion, whereas the cytoplasmic domain serves to
link the cadherin to the cytoskeleton via interactions with
catenins. These cytosolic interactions are critical to the ad-
hesive function of the cadherin. Linkage to the cytoskele-
ton is necessary to promote strong cell–cell adhesion and
to allow organization of the junction itself. In addition, the
catenins have been implicated in signaling events that are
thought to regulate the strength of the adhesive activity of
the cadherin (for review see Gumbiner, 2000). This led us
to propose that the cytoplasmic domain of N-cadherin was
responsible for increasing the motility of epithelial cells.
When we prepared two chimeric cadherins, one comprised
of the extracellular domain of N-cadherin linked to the cy-
toplasmic domain of E-cadherin (N/E-cadherin) and the
other comprised of the extracellular domain of E-cadherin
linked to the cytoplasmic domain of N-cadherin (E/N-cad-
herin), we were surprised to find that it was the extracellu-
lar domain of N-cadherin that promoted cell motility. The
extracellular domain of cadherins is comprised of five re-
peat regions with EC1 being the most NH
 
2
 
-terminal. Most
of the known activities of cadherins have been mapped to
EC1. The best understood examples are those where cad-
herin molecules interact with other cadherin molecules.
Structure determinations (Shapiro et al.,1995; Nagar et al.,
1996; Tamura et al., 1998; Pertz et al., 1999) and biochemi-
cal characterization (Nose et al., 1990; Ozawa et al., 1990;
Ozawa and Kemler, 1990; Koch et al., 1997; Shan et al.,
2000) have demonstrated that EC1 is the site of the adhe-
sion interface. Data from several laboratories have sug-
gested that cadherins are displayed on the surface of cells
as dimers (Shapiro et al., 1995; Brieher et al., 1996; Chi-
taev and Troyanovsky, 1998; Takeda et al., 1999; Shan et
al., 2000). Although several differing pictures exist as to
how these cis (also called lateral) dimers form and are
maintained, the data point to EC1 and EC2 of the cad-
herins as playing major roles.
In some instances, it has been shown that cadherins can
promote cell–cell adhesion via heterophilic interactions,
for example N-cadherin can bind to R-cadherin (Inuzuka
et al., 1991), B-cadherin can bind to L-CAM (Murphy-
Erdosh et al., 1995), and cadherin-6B can bind to cadherin-7
(Nakagawa and Takeichi, 1995). Recently, Shimoyama et
al. (2000) examined eight different type II cadherins and
frequently observed interactions between L cells trans-
fected with different cadherins. Another recent study
showed that, in L cells expressing both N- and R-cad-
herins, the two cadherins formed cis heterodimers that
functioned in cell adhesion (Shan et al., 2000). In this latter
case, it was the NH
 
2
 
 terminus of the cadherins that played
a role in the formation of the cis heterodimers. It will be in-
teresting to determine if other pairs of cadherins shown to
mediate heterophilic cell–cell adhesion are able to form cis
Figure 7. Anti–N-cadherin mAb 8C11 inhibits motility. (A) Ex-
tracts of A431D cells transfected with N/E-myc-cadherin (lanes 1
and 7), N/E5a-myc-cadherin (lanes 2 and 8), N/E5-myc-cadherin
(lanes 3 and 9), N/E4-myc-cadherin (lanes 4 and 10), N/E3-myc-
cadherin (lanes 5 and 11), or N/E2-myc-cadherin (lanes 6 and 12)
were resolved by SDS-PAGE and immunoblotted with mAb
8C11 (lanes 1–6) or anti-myc (lanes 7–12). Note, in some cases,
we observed various processing variants when transfected cad-
herins were overexpressed in cells. (B) BT20 cells, which were
transfected with N-cadherin (BT20N), were plated on mem-
branes for motility assays in the presence of no antibody or 8C11
ascites at a dilution of 1:10–1:100. Untransfected BT20 cells in the
absence of antibody were included as a control. After 24 h, the
number of cells traversing the membrane was determined by av-
eraging 10 random fields at 1003 magnification. Data are ex-
pressed as the number of cells/field. (C) Untransfected BT20
cells or BT20 cells transfected with N-cadherin (BT20N) were
plated on membranes for motility assays in the presence of no an-
tibody, irrelevant ascites 4A2 at a dilution of 1:10 or 8C11 ascites
at a dilution of 1:10. After 24 h, the number of cells traversing the
membrane was determined by counting the entire membrane.
Data are expressed as the number of cells traversing the filter. 
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heterodimers and what parts of the cadherins are involved.
Here, we have shown that the ability of N-cadherin to pro-
mote cell motility resides in EC-4. Thus, this activity is dis-
tinct from the adhesive function of the cadherin.
In addition to the interaction of cadherins with themselves,
various other interacting proteins have been described. The
bacterium 
 
Listeria monocytogenes
 
 has been shown to use
E-cadherin as a receptor. InlA, a surface protein on the bac-
terium, binds to E-cadherin. Lecuit et al. (1999) showed that
changing a single amino acid in EC1 of E-cadherin (proline-
16 of EC1) eliminated the binding of InlA and dramatically
compromised internalization of 
 
Listeria
 
 by cells. In addition
to being a target for 
 
Listeria
 
, E-cadherin is the only cadherin
that is known to be an integrin ligand. Integrin 
 
a
 
E
 
b
 
7
 
 binds
EC1 of E-cadherin, and glutamate-31 of EC1 plays a critical
role in the interaction (Karecla et al., 1996). Since EC1 of
cadherins has been shown to play a major role in their biolog-
ical activities, all of the chimeras used here retained the intact
EC1 of N-cadherin.
Although most activities have been mapped to the NH
 
2
 
-
terminal domains, there are several reports suggesting
roles for EC3, EC4, and EC5 in cadherin adhesion. Zhong
et al. (1999) have characterized a mAb (AA5) recognizing
EC5 of C-cadherin that activates adhesion, perhaps by
changing the cadherin’s organization or altering its inter-
action with other cellular factors. Sivasankar et al. (1999)
have studied the biophysical characteristics of adhesion
mediated by layers of oriented recombinant C-cadherin
ectodomains. They concluded that complete interdigita-
tion of antiparallel ectodomains (i.e., where EC1 of one
molecule interacted with EC5 of the antiparallel partner,
EC2 interacted with EC4 of the partner, etc.) gave the
strongest interactions. Their data also suggested that
ratcheting the molecules one EC domain further apart
(such that EC1 interacted with EC4 of its antiparallel part-
ner, etc.) also resulted in an adhesive interaction. In addi-
tion, Troyanovsky et al. (1999) have reported that EC3
and EC4 of E-cadherin can mediate cis dimerization under
some conditions.
A series of papers from Lilien’s laboratory (for review
see Lilien et al., 1999) have suggested that in neural retina
cells, the ectodomain of N-cadherin is stably associated with
and is a substrate for the cell surface enzyme 
 
N
 
-acetylgalac-
tosaminyphosphotransferase. The interaction of neurocan,
a chondroitin sulfate proteoglycan, with 
 
N
 
-acetylgalacto-
saminyphosphotransferase results in inhibition of N-cad-
herin–mediated cell adhesion. However, the site(s) on N-cad-
herin where this interaction takes place is unknown.
Investigators have suggested that N-cadherin can inter-
act with and activate fibroblast growth factor receptors
(FGFR) in neurons (Doherty and Walsh, 1996) and ovarian
surface epithelial cells (Peluso, 2000). In the ovarian surface
epithelial cell system, it has been reported that N-cadherin
and FGFR coimmunoprecipitate. To date, this interaction
has not been substantiated by other labs. Our laboratory re-
cently showed that N-cadherin–mediated cell motility of
breast cancer cells can be decreased by an inhibitor of the
FGF-mediated signal transduction pathway, which has been
characterized by the Walsh and Doherty labs (Nieman et
al., 1999a). In addition, Hazan et al. (2000) showed that
FGF caused a dramatic increase in motility in N-cadherin–
expressing cells. The FGFRs contain an HAV sequence
 
(Byers et al., 1992) that has been proposed to interact with
EC4 of N-cadherin. It is interesting to note that the 69–
amino acid segment of N-cadherin we have identified here
includes the sequences proposed by Doherty and Walsh to
interact with the FGFRs. The structure of a portion of
FGFR1 bound to FGF2 has been determined (Plotnikov et
al., 1999). The histidine and valine side chains of the HAV
sequence in FGFR1 were involved in intradomain contacts
and, thus, appear to be unavailable for interacting with part-
ner molecules. Thus, the precise role the FGFR plays in
N-cadherin–dependent cell motility is still unknown and it
is not clear at this time whether N-cadherin and the FGFR
directly interact with one another.
Many studies have shown that N-cadherin promotes cell
motility that is dependent on the adhesive function of
N-cadherin. The best studied example is that of N-cad-
herin–dependent neurite extension. In vitro experiments
have demonstrated that N-cadherin promotes neurite out-
growth as a purified protein or when it is expressed by
transfected cells. Importantly, antibodies that block the
adhesive function of N-cadherin block this outgrowth, and
it has been suggested that N-cadherin may guide axonal
outgrowth in vivo (for review see Grunwald, 1996). In ad-
dition, Hazan et al. (1997) suggested that N-cadherin–
mediated motility of tumor cells might be due to the in-
teractions of N-cadherin–expressing epithelial cells with
N-cadherin–expressing stromal cells. In contrast, the stud-
ies presented here, using the 8C11 mAb, provide evidence
that N-cadherin may influence the motility of epithelial
cells in a manner that is independent of cell–cell adhesion.
Since the 69–amino acid portion of N-cadherin can influ-
ence epithelial cell morphology and motility, we compared
this portion of human N-cadherin to other cadherins. In
this region, mouse and rat N-cadherin are identical to hu-
man N-cadherin, whereas 78% of the amino acids in hu-
man R-cadherin are identical. The corresponding region of
human E-cadherin contains 70 amino acids and is 54%
identical to N-cadherin. To further investigate the role this
portion of N-cadherin plays in cell motility, we produced a
mAb that binds near EC-4 of N-cadherin. When applied to
cells in a motility assay, this antibody inhibited cell motility
in N-cadherin–expressing cells, but not in N-cadherin–neg-
ative cells. In addition, this antibody inhibited motility
without inhibiting cell–cell aggregation, providing further
evidence that adhesion and motility are two separate prop-
erties of the extracellular domain of N-cadherin. It is im-
portant to remember that all the chimeras used here were
full-length cadherins. Studies are in progress to determine
if truncated cadherins can influence cell motility.
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